
Gigi Georgiana Huang
Examiner (ID: 12753)
| Most Active Art Unit | 1613 |
| Art Unit(s) | 1618, 1627, 1629, 1609, 1612, 1613, 1617, 1621 |
| Total Applications | 781 |
| Issued Applications | 217 |
| Pending Applications | 66 |
| Abandoned Applications | 506 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5029001
[patent_doc_number] => 20070270448
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-22
[patent_title] => 'Methods of Using and Compositions Comprising a Jnk Inhibitor for the Treatment and Management of Asbestos-Related Diseases and Disorders'
[patent_app_type] => utility
[patent_app_number] => 10/578809
[patent_app_country] => US
[patent_app_date] => 2004-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20672
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0270/20070270448.pdf
[firstpage_image] =>[orig_patent_app_number] => 10578809
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/578809 | Methods of Using and Compositions Comprising a Jnk Inhibitor for the Treatment and Management of Asbestos-Related Diseases and Disorders | Nov 3, 2004 | Abandoned |
Array
(
[id] => 5193553
[patent_doc_number] => 20070082037
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-12
[patent_title] => 'Transdermal preparations and method for relieving side effects in pergolide therapy'
[patent_app_type] => utility
[patent_app_number] => 10/577746
[patent_app_country] => US
[patent_app_date] => 2004-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6397
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20070082037.pdf
[firstpage_image] =>[orig_patent_app_number] => 10577746
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/577746 | Transdermal preparations and method for relieving side effects in pergolide therapy | Oct 28, 2004 | Abandoned |
Array
(
[id] => 6971273
[patent_doc_number] => 20050036983
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-17
[patent_title] => 'In vivo use of water absorbent polymers'
[patent_app_type] => utility
[patent_app_number] => 10/949859
[patent_app_country] => US
[patent_app_date] => 2004-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5271
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0036/20050036983.pdf
[firstpage_image] =>[orig_patent_app_number] => 10949859
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/949859 | In vivo use of water absorbent polymers | Sep 23, 2004 | Abandoned |
Array
(
[id] => 6971362
[patent_doc_number] => 20050037072
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-17
[patent_title] => 'Pharmaceutical compositions for rectal and vaginal administration'
[patent_app_type] => utility
[patent_app_number] => 10/946556
[patent_app_country] => US
[patent_app_date] => 2004-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2879
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20050037072.pdf
[firstpage_image] =>[orig_patent_app_number] => 10946556
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/946556 | Pharmaceutical compositions for rectal and vaginal administration | Sep 20, 2004 | Abandoned |
Array
(
[id] => 5183586
[patent_doc_number] => 20070054940
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-08
[patent_title] => 'Remedy for down\'s syndrome'
[patent_app_type] => utility
[patent_app_number] => 10/572090
[patent_app_country] => US
[patent_app_date] => 2004-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6737
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20070054940.pdf
[firstpage_image] =>[orig_patent_app_number] => 10572090
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/572090 | Remedy for down's syndrome | Sep 16, 2004 | Abandoned |
Array
(
[id] => 5904659
[patent_doc_number] => 20060047005
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-02
[patent_title] => 'Compositions containing N,N,N\',N\'-tetrakis(hydroxyalkyl)diamine-or N,N,N\',N\'-tetrakis(hydroxyalkoxy)diamine-based buffers'
[patent_app_type] => utility
[patent_app_number] => 10/926504
[patent_app_country] => US
[patent_app_date] => 2004-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6485
[patent_no_of_claims] => 92
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0047/20060047005.pdf
[firstpage_image] =>[orig_patent_app_number] => 10926504
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/926504 | Compositions containing N,N,N',N'-tetrakis(hydroxyalkyl)diamine-or N,N,N',N'-tetrakis(hydroxyalkoxy)diamine-based buffers | Aug 25, 2004 | Abandoned |
Array
(
[id] => 5904462
[patent_doc_number] => 20060046958
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-02
[patent_title] => 'Compositions and methods comprising prostaglandin related compounds and trefoil factor family peptides for the treatment of glaucoma with reduced hyperemia'
[patent_app_type] => utility
[patent_app_number] => 10/521367
[patent_app_country] => US
[patent_app_date] => 2004-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6263
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20060046958.pdf
[firstpage_image] =>[orig_patent_app_number] => 10521367
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/521367 | Compositions and methods comprising prostaglandin related compounds and trefoil factor family peptides for the treatment of glaucoma with reduced hyperemia | Aug 24, 2004 | Issued |
Array
(
[id] => 5687858
[patent_doc_number] => 20060286173
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-21
[patent_title] => 'Drug delivery system for sub-tenon s capsule adminstration of fine grains'
[patent_app_type] => utility
[patent_app_number] => 10/568892
[patent_app_country] => US
[patent_app_date] => 2004-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4504
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20060286173.pdf
[firstpage_image] =>[orig_patent_app_number] => 10568892
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/568892 | Drug delivery system for sub-tenon s capsule adminstration of fine grains | Aug 19, 2004 | Abandoned |
Array
(
[id] => 5835389
[patent_doc_number] => 20060247220
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-02
[patent_title] => 'Preventing the crystallization of cholesterol using oxysterols'
[patent_app_type] => utility
[patent_app_number] => 10/568676
[patent_app_country] => US
[patent_app_date] => 2004-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1658
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20060247220.pdf
[firstpage_image] =>[orig_patent_app_number] => 10568676
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/568676 | Preventing the crystallization of cholesterol using oxysterols | Aug 18, 2004 | Abandoned |
Array
(
[id] => 5590520
[patent_doc_number] => 20060039971
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-23
[patent_title] => 'Effervescent composition including alternative hormone replacement therapy agent'
[patent_app_type] => utility
[patent_app_number] => 10/921698
[patent_app_country] => US
[patent_app_date] => 2004-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4066
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20060039971.pdf
[firstpage_image] =>[orig_patent_app_number] => 10921698
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/921698 | Effervescent composition including alternative hormone replacement therapy agent | Aug 18, 2004 | Abandoned |
Array
(
[id] => 7024965
[patent_doc_number] => 20050019359
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-27
[patent_title] => 'Cosmetic films'
[patent_app_type] => utility
[patent_app_number] => 10/919736
[patent_app_country] => US
[patent_app_date] => 2004-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6505
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20050019359.pdf
[firstpage_image] =>[orig_patent_app_number] => 10919736
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/919736 | Cosmetic films | Aug 16, 2004 | Abandoned |
Array
(
[id] => 7145650
[patent_doc_number] => 20050119262
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-02
[patent_title] => 'Method for preventing or treating an optic neuropathy with a cox-2 inhibitor and an intraocular pressure reducing agent'
[patent_app_type] => utility
[patent_app_number] => 10/919835
[patent_app_country] => US
[patent_app_date] => 2004-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16149
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20050119262.pdf
[firstpage_image] =>[orig_patent_app_number] => 10919835
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/919835 | Method for preventing or treating an optic neuropathy with a cox-2 inhibitor and an intraocular pressure reducing agent | Aug 16, 2004 | Abandoned |
Array
(
[id] => 7088585
[patent_doc_number] => 20050008697
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-13
[patent_title] => 'Oral solid solution formulation of a poorly water-soluble active substance'
[patent_app_type] => utility
[patent_app_number] => 10/915560
[patent_app_country] => US
[patent_app_date] => 2004-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4203
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20050008697.pdf
[firstpage_image] =>[orig_patent_app_number] => 10915560
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/915560 | Oral solid solution formulation of a poorly water-soluble active substance | Aug 10, 2004 | Abandoned |
Array
(
[id] => 7033188
[patent_doc_number] => 20050031697
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-10
[patent_title] => 'Compositions for delivery of therapeutics into the eyes and methods for making and using same'
[patent_app_type] => utility
[patent_app_number] => 10/911966
[patent_app_country] => US
[patent_app_date] => 2004-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12937
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20050031697.pdf
[firstpage_image] =>[orig_patent_app_number] => 10911966
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/911966 | Compositions for delivery of therapeutics into the eyes and methods for making and using same | Aug 4, 2004 | Issued |
Array
(
[id] => 5873163
[patent_doc_number] => 20060165793
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-27
[patent_title] => 'Pharmaceutical preparation to be dispersed before administration'
[patent_app_type] => utility
[patent_app_number] => 10/564402
[patent_app_country] => US
[patent_app_date] => 2004-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5177
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20060165793.pdf
[firstpage_image] =>[orig_patent_app_number] => 10564402
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/564402 | Pharmaceutical preparation to be dispersed before administration | Aug 3, 2004 | Abandoned |
Array
(
[id] => 7088591
[patent_doc_number] => 20050008703
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-13
[patent_title] => 'Medical formulation containing a muscarinic agonist'
[patent_app_type] => utility
[patent_app_number] => 10/909772
[patent_app_country] => US
[patent_app_date] => 2004-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2936
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20050008703.pdf
[firstpage_image] =>[orig_patent_app_number] => 10909772
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/909772 | Medical formulation containing a muscarinic agonist | Aug 1, 2004 | Abandoned |
Array
(
[id] => 7088586
[patent_doc_number] => 20050008698
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-13
[patent_title] => 'Base material for dry direct tableting comprising low-substituted hydroxypropyl cellulose'
[patent_app_type] => utility
[patent_app_number] => 10/909236
[patent_app_country] => US
[patent_app_date] => 2004-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3663
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20050008698.pdf
[firstpage_image] =>[orig_patent_app_number] => 10909236
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/909236 | Base material for dry direct tableting comprising low-substituted hydroxypropyl cellulose | Jul 29, 2004 | Abandoned |
Array
(
[id] => 7010494
[patent_doc_number] => 20050064210
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-24
[patent_title] => 'Coating for use with medical devices and method of making same'
[patent_app_type] => utility
[patent_app_number] => 10/900016
[patent_app_country] => US
[patent_app_date] => 2004-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3370
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20050064210.pdf
[firstpage_image] =>[orig_patent_app_number] => 10900016
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/900016 | Coating for use with medical devices and method of making same | Jul 25, 2004 | Abandoned |
Array
(
[id] => 5769495
[patent_doc_number] => 20060020044
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-26
[patent_title] => 'Methods and compositions for treating or preventing macular-degeneration related disorders'
[patent_app_type] => utility
[patent_app_number] => 10/898893
[patent_app_country] => US
[patent_app_date] => 2004-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6817
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20060020044.pdf
[firstpage_image] =>[orig_patent_app_number] => 10898893
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/898893 | Methods and compositions for treating or preventing macular-degeneration related disorders | Jul 25, 2004 | Abandoned |
Array
(
[id] => 7435419
[patent_doc_number] => 20040266792
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-30
[patent_title] => 'Hydroxyrisperidone compositions and methods'
[patent_app_type] => new
[patent_app_number] => 10/891236
[patent_app_country] => US
[patent_app_date] => 2004-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3228
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0266/20040266792.pdf
[firstpage_image] =>[orig_patent_app_number] => 10891236
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/891236 | Hydroxyrisperidone compositions and methods | Jul 12, 2004 | Abandoned |